GB Patent

GB0002666D0 — Blockade of voltage dependent sodium channels

Assigned to University College London · Expires 2000-03-29 · 26y expired

What this patent protects

Compounds of Formula I and pharmaceutically acceptable salts thereof, are capable of blockading voltage-dependent sodium channels and are useful in particular, in treating glaucoma and multiple sclerosis.

USPTO Abstract

Compounds of Formula I and pharmaceutically acceptable salts thereof, are capable of blockading voltage-dependent sodium channels and are useful in particular, in treating glaucoma and multiple sclerosis.

Drugs covered by this patent

Patent Metadata

Patent number
GB0002666D0
Jurisdiction
GB
Classification
—
Expires
2000-03-29
Drug substance claim
No
Drug product claim
No
Assignee
University College London
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.